TD Securities set a C$10.50 price target on Trilogy International Partners Inc (TSE:TRL) in a research note issued to investors on Friday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.
Separately, Scotiabank reissued an outperform rating and set a C$13.00 price target on shares of Trilogy International Partners in a report on Monday, May 15th.
Trilogy International Partners (TSE:TRL) traded up 0.192% on Friday, hitting $7.815. The stock had a trading volume of 800 shares. The stock has a 50 day moving average price of $8.34 and a 200 day moving average price of $9.33. Trilogy International Partners has a 1-year low of $7.54 and a 1-year high of $10.48. The company’s market cap is $332.24 million.
TRADEMARK VIOLATION NOTICE: This story was originally posted by Markets Daily and is the property of of Markets Daily. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.themarketsdaily.com/2017/08/13/trilogy-international-partners-inc-tsetrl-given-a-c10-50-price-target-by-td-securities-analysts.html.
About Trilogy International Partners
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.